Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 1356 add-on to metformin in type 2 diabetes
2005-004597-24Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of linagliptin in type 2 diabetes mellitus (T2DM) (5 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change in HbA1c from baseline to week 12. Started Feb 2006; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-004597-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004597-24.